From April 2019 News & Views: Managing access to gene therapy, mitigating risk of inappropriate opioid utilization, the current state of value-based contracting, and drug pricing reform efforts are just some topics of the nearly 40 educational sessions that took place at the AMCP Managed Care & Specialty Pharmacy Annual Meeting last week in San Diego.
From April 2019 News & Views: Nearly 4,200 Attendees Gather for AMCP Annual Meeting; Revitalized AMCP Brand Reflects Forward-Thinking Approach; CEO Susan A. Cantrell Blog; AMPC President James Kenney Addresses General Session
In diabetic patients, treatment intensification with insulin or GLP-1RA after failure of two oral anti-diabetic agents resulted in improved glycemic control, according to a retrospective cohort published in JMCP.
A retrospective study in JMCP found that pharmacist-adjudicated prior authorization drug requests result in substantial economic benefit, and the prevention of adverse events.
Partnership Forum: This Forum brought together industry leaders to consider P&T practices that reflect the current health care system and provide recommendations to allow for a transparent P&T process in today’s health care system.
AMCP CEO Address: AMCP CEO Susan A. Cantrell, RPh, CAE addressed the AMCP 2019 Annual Meeting on March 26, laying out how AMCP is prepared to meet the challenges of today’s complex health care system. The following is a lightly edited transcript of that address.
